tradingkey.logo
tradingkey.logo
Suchen

Codexis Inc

CDXS
Zur Watchlist hinzufügen
2.470USD
+0.080+3.35%
Handelsschluss 07/02, 13:00ETKurse um 15 Minuten verzögert
222.99MMarktkapitalisierung
VerlustKGV TTM

mehr Informationen über Codexis Inc Unternehmen

Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Codexis Inc Informationen

BörsenkürzelCDXS
Name des UnternehmensCodexis Inc
IPO-datumApr 22, 2010
CEOMoore (Alison)
Anzahl der mitarbeiter188
WertpapierartOrdinary Share
GeschäftsjahresendeApr 22
Addresse200 Penobscot Dr
StadtREDWOOD CITY
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl94063
Telefon16504218100
Websitehttps://www.codexis.com/
BörsenkürzelCDXS
IPO-datumApr 22, 2010
CEOMoore (Alison)

Führungskräfte von Codexis Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--
Ms. Cynthia Collins
Ms. Cynthia Collins
Independent Director
Independent Director
112.16K
--
Mr. Christos Richards
Mr. Christos Richards
Independent Director
Independent Director
85.13K
--
Dr. Raymond De Vre, Ph.D.
Dr. Raymond De Vre, Ph.D.
Independent Director
Independent Director
84.81K
-3.07%
Ms. Georgia L. Erbez
Ms. Georgia L. Erbez
Chief Financial Officer
Chief Financial Officer
66.81K
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Dr. Alison Moore, Ph.D.
Dr. Alison Moore, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
250.51K
+30.69%
Mr. David V. Smith
Mr. David V. Smith
Lead Independent Director
Lead Independent Director
194.28K
--
Mr. Kevin Norrett
Mr. Kevin Norrett
Chief Operating Officer
Chief Operating Officer
160.27K
+9.69%
Mr. Dennis P. Wolf
Mr. Dennis P. Wolf
Independent Director
Independent Director
138.95K
-6.44%
Dr. Rahul Singhvi
Dr. Rahul Singhvi
Independent Director
Independent Director
137.05K
+3.65%
Dr. Esther Martinborough, Ph.D.
Dr. Esther Martinborough, Ph.D.
Independent Director
Independent Director
129.04K
--

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von Codexis Inc?

Die fünf größten Anteilseigner von Codexis Inc sind: Dr. Alison Moore, Ph.D.

Wie viele Institutionen halten Anteile an Codexis Inc (CDXS)?

Mit Stand vom 2026Q1 halten 273 Institutionen Anteile an Codexis Inc, mit einem Gesamtmarktwert von etwa 66.34M, was 73.00% der Gesamtanteile entspricht. Im Vergleich zum 2025Q4 ist der institutionelle Aktienbesitz um -13883230.00 gestiegen.